The Art of Drug Synthesis [Hardcover]

$110.99     $156.95   29% Off     (Shipping shown at checkout) (Free Shipping)
available
  • Category: Books (Medical)
  • ISBN-10:  0471752150
  • ISBN-10:  0471752150
  • ISBN-13:  9780471752158
  • ISBN-13:  9780471752158
  • Publisher:  Wiley-Interscience
  • Publisher:  Wiley-Interscience
  • Pages:  296
  • Pages:  296
  • Binding:  Hardcover
  • Binding:  Hardcover
  • Pub Date:  01-May-2007
  • Pub Date:  01-May-2007
  • SKU:  0471752150-11-SPLV
  • SKU:  0471752150-11-SPLV
  • Item ID: 100899644
  • List Price: $156.95
  • Seller:
  • Ships in: business days
  • Transit time: Up to business days
  • Delivery by: to
  • Notes:
  • Restrictions:
  • Limit: per customer
  • Cart Requirements: .MIN_ORD_MSG}}

The Art of Drug Synthesis illustrates how chemistry, biology, pharmacokinetics, and a host of other disciplines come together to produce successful medicines. The authors have compiled a collection of 21 representative categories of drugs, from which they have selected as examples many of the best-selling drugs on the market today. An introduction to each drug is provided, as well as background to the biology, pharmacology, pharmacokinetics, and drug metabolism, followed by a detailed account of the drug synthesis.

  • Edited by prominent scientists working in drug discovery for Pfizer
  • Meets the needs of a growing community of researchers in pharmaceutical R&D
  • Provides a useful guide for practicing pharmaceutical scientists as well as a text for medicinal chemistry students
  • An excellent follow-up to the very successful first book by these editors, Contemporary Drug Synthesis, but with all new therapeutic categories and drugs discussed.

Foreword xi

Preface xiii

Contributors xv

1 THE ROLE OF MEDICINAL CHEMISTRY IN DRUG DISCOVERY 1
John A. Lowe, III

1.1 Introduction 1

1.2 Hurdles in the Drug Discovery Process 2

1.3 The Tools of Medicinal Chemistry 3

1.4 The Role of Synthetic Chemistry in Drug Discovery 6

2 PROCESS RESEARCH: HOW MUCH? HOW SOON? 11
Neal G. Anderson

2.1 Introduction 11

2.2 Considerations for Successful Scale-up to Tox Batches and Phase I Material 15

2.3 Considerations for Phase 2 Material and Beyond 16

2.4 Summary 26

I CANCER AND INFECTIOUS DISEASES

3 AROMATASE INHIBITORSlc